Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms

Intern Med. 2014;53(21):2515-9. doi: 10.2169/internalmedicine.53.2769. Epub 2014 Nov 1.

Abstract

We herein report a patient with clinically amyopathic dermatomyositis (CADM) who developed anti-CADM-140 autoantibody in association with rapidly progressive interstitial lung disease (RP-ILD). Chest high-resolution computed tomography (HRCT) revealed early pulmonary involvement preceding typical cutaneous lesions. Primary lesions of patchy peribronchial opacity developed ground-glass opacity and consolidation with architectural distortion and traction bronchiectasis. The possibility of anti-CADM-140 autoantibody-associated RP-ILD should be considered when patchy peribronchial opacity of an unknown cause is visible on chest HRCT.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies / blood*
  • Dermatomyositis / blood
  • Dermatomyositis / complications*
  • Dermatomyositis / diagnosis*
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Lung Diseases, Interstitial / blood
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / etiology*
  • Middle Aged
  • Peptides / immunology*

Substances

  • Autoantibodies
  • CADM-140 peptide, human
  • Intercellular Signaling Peptides and Proteins
  • Peptides

Supplementary concepts

  • Amyopathic dermatomyositis